Counterpoint: Implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias do not increase mortality

Heart Rhythm

Volumn 9, Issue 6, 2012, Pages 988-991

  Dorian, Paul ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Defibrillator therapy; Implantable cardioverter defibrillator; Shocks

Indexed keywords

AZIMILIDE; PLACEBO;

DEFIBRILLATOR; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HOSPITALIZATION; HUMAN; MORTALITY; NOTE; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 84861335204     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.11.037     Document Type: Article

References (12)

1. N.A. Estes III Predicting and preventing sudden cardiac death Circulation 124 2011 651 656
2. S.H. Hohnloser, K.H. Kuck, P. Dorian DINAMIT Investigators Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
3. G. Steinbeck, D. Andresen, K. Seidl IRIS Investigators Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
4. J.E. Poole, G.W. Johnson, A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
5. A.J. Moss, H. Greenberg, R.B. Case Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
6. P. Dorian, S.H. Hohnloser, K.E. Thorpe Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT) Circulation 122 2010 2645 2652
7. M.O. Sweeney The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death Circulation 122 2010 2638 2641
8. S. Yusuf, J. Wittes, J. Probstfield, H.A. Tyroler Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JAMA 266 1991 93 98
9. B. Powell ALTITUDE: "inappropriate" ICD shocks off the hook for mortality increase The Heart Rhythm Society (HRS) 2011 Scientific Session, Late Breaking Trials www.theheart.org/article/1221745/print.do Accesssed December 16, 2011
10. S.P. Bhavnani, J. Kluger, C.I. Coleman The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators Heart Rhythm 7 2010 755 760
11. M.O. Sweeney, L. Sherfesee, P.J. DeGroot, M.S. Wathen, B.L. Wilkoff Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients Heart Rhythm 7 2010 353 360
12. P. Dorian, H.R. Al-Khalidi, S.H. Hohnloser Shock Inhibition Evaluation with AzimiLiDe (SHIELD) Investigators Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter- defibrillator in a placebo-controlled clinical trial J Am Coll Cardiol 52 2008 1076 1083